Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06365970
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-06
First Post:
2024-03-29
Brief Title:
Niraparib and Dostarlimab for Patients With MMR-DMSI-H Colorectal Cancers
Sponsor:
Ibrahim Halil Sahin
Organization:
University of Pittsburgh
Organization Data
Organization:
University of Pittsburgh
Class:
OTHER
Study ID:
HCC 23-056
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ibrahim Halil Sahin
Lead Sponsor Class:
OTHER
Responsible Party:
Ibrahim Halil Sahin
Responsible Party Title:
Assistant Professor of Medical oncology
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Pittsburgh
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |